Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
drugs
11
×
life sciences
national blog main
boston blog main
boston top stories
clinical trials
boston
fda
alnylam pharmaceuticals
national top stories
new york blog main
new york top stories
aminolevulinic acid
cancer
givosiran
news
onpattro
patisiran
rna interference
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
accelerated approval
acute hepatic porphyria
acute hepatic porphyrias
akcea therapeutics
akin akinc
aldehyde
aldeyra therapeutics
allergic conjunctivitis
allopregnanolone
biotechnology
blueprint medicines
boulder/denver blog main
boulder/denver top stories
brexanolone
cannabidiol
carla grandori
companion diagnostic
What
drug
11
×
medicine
11
×
fda
new
alnylam
approved
data
interference
pharmaceuticals
rna
rnai
second
ago
cancer
chronic
drugs
involving
market
oks
pain
post
recall
seek
speedy
time
way
weeks
aid
aldeyra
appeared
approach
approval
approves
attention
aware
battle
bottles
brexanolone
bryant
cannabis
Language
unset
Current search:
drugs
×
medicine
×
drug
×
@bgr.com
1 year ago
Urgent medicine recall: A serious dosage mistake can lead to overdose and death
@bgr.com
2 years ago
Major drug recall: This company recalled every medicine it makes, so check your home
@geekwire.com
4 years ago
Fred Hutch spinout SEngine raises $5.1M to test cancer treatment drugs against a patient’s tumors
@xconomy.com
5 years ago
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com
5 years ago
With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug
@extremetech.com
7 years ago
Drug delivery implants could change the way we approach chronic conditions